Drug and device manufacturers are increasingly targeted by cyber threats that can compromise patient safety, intellectual property, and other critical data and systems, while also facing new regulatory demands. As regulators...more
7/31/2025
/ Cyber Insurance ,
Cybersecurity ,
Data Privacy ,
Data Protection ,
Food and Drug Administration (FDA) ,
FTC Act ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Information Security ,
Intellectual Property Protection ,
Life Sciences ,
Manufacturers ,
Medical Devices ,
Pharmaceutical Industry ,
PHI ,
Regulatory Requirements ,
Risk Management